Business Wire

NY-AMERICAN-EXPRESS

12.3.2024 14:01:28 CET | Business Wire | Press release

Share
American Express Reveals 2024 Top Travel Trends

American Express Travel® released its 2024 Global Travel Trends Report1 today, highlighting the inspiration and trends driving global travel bookings this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312265470/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

American Express Reveals 2024 Top Travel Trends. (Photo: Business Wire)

The report, based on survey data from travelers in the United States, Australia, Canada, India, Japan, Mexico, and the United Kingdom, found that 84% of respondents plan to spend more or the same amount of money on travel in 2024 compared to last year. Additionally, 77% of respondents care more about having the right travel experience than about the cost of the trip.

The four trends driving booking decisions are:

  • For the Love of the Game: Sports fans are planning trips around athletic events, whether it involves a favorite sport, a beloved team, or an international multi-sport competition
  • Planning Big: Major, expedition-style adventures, like a trip to the Galapagos Islands or trekking with the gorillas, deliver the transformative experiences that travelers are looking for
  • Going Solo: Travelers are takings trips alone, embracing the ease of planning and ability to tailor itineraries that are a perfect fit
  • On a Whim: With so much of life being structured and scheduled these days, people are seeking flexibility in their travel plans and leaving room for spontaneity

“Travelers are focused on creating the right itineraries and building memories, whether that means booking a trip to see a favorite sports team compete or taking a once-in-a-lifetime expedition cruise,” says Audrey Hendley, President of American Express Travel. “Our Global Travel Trends Report sheds light on what is driving global travel bookings and provides inspiration for where to go next. Our American Express Travel Consultants can help, no matter what type of trip you want to take.”

Top insights from American Express Travel’s 2024 Global Travel Trends Report include:

  • A desire to see sporting events live and to watch favorite teams and beloved players in person are driving where travelers are going and what they are doing when they get there.
    • 67% of Millennial and Gen Z respondents2 (compared to 58% of all respondents) are interested in traveling for sporting events in 2024
    • 58% of respondents who are traveling for sports in 2024 will do so for soccer, basketball or Formula 1 racing
    • New York, Miami and Paris are the top destinations respondents are planning to travel to for sporting events this summer
  • Transformative, once-in-a-lifetime trips, like visiting the Galapagos Islands and hiking in Antarctica, are at the top of many travelers’ wish lists, and younger travelers want an expert to help them plan.
    • 65% of respondents are more interested in taking a major trip in 2024 than in previous years
    • 72% of respondents would rather save money for a major trip than spend it on going out with friends; and more than half of respondents plan on saving between 6 months to 2 years for a major trip
    • 58% of Millennial and Gen Z respondents want a travel agent or trusted advisor to help them book a major trip this year
    • 55% of respondents planning a major trip would consider visiting multiple countries in a region
  • The ease of planning and ability to make the perfect, personalized itinerary is driving people to plan trips alone, especially younger travelers.
    • 76% of Millennials and Gen Z respondents (compared to 69% of all respondents) say they are planning on taking a solo trip 2024
    • 74% of male respondents and 63% of female respondents say they are planning on taking a solo trip in 2024
    • 66% of respondents planning on traveling solo are planning a trip tailored to treat themselves
    • 60% of respondents planning on traveling solo this year intend to take two or more solo trips
  • Travelers are leaning into flexible itineraries, allowing them the freedom to be spontaneous and experience the local culture when they travel.
    • 78% of respondents say that spontaneous trips appeal to them
    • 77% of Millennials and Gen Z have booked a last-minute trip before, compared to 65% of Gen X3 and 52% of Baby Boomers4
    • 68% of respondents agree that they like to leave unplanned time in their trip to experience local culture/activities
    • 57% of respondents prefer booking a last-minute getaway to a nearby destination rather than somewhere far away

As the demand for travel continues into 2024, American Express provides eligible Card Members with exceptional travel access and experiences, including 1,400+ airport lounges through its Global Lounge Collection®; expert Travel Consultants who can build dream itineraries for everything from major trips like an expedition cruise or safari, to quick weekend getaways; restaurant reservations through Resy and curated where-to-eat guides at Resy.com/Travel; benefits across global sporting experiences and venues; benefits at over 2,000 hand-picked hotels around the world via Fine Hotels + Resorts® and The Hotel Collection; more than 1,000 premium vacation rental properties via Select Homes + RetreatsTM, and more.

The full American Express Travel 2024 Global Travel Trends Report can be viewed here.

ABOUT AMERICAN EXPRESS

American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, threads.net/@americanexpress, tiktok.com/@americanexpress, linkedin.com/company/american-express, twitter.com/americanexpress, and youtube.com/americanexpress.

Key links to products, services and corporate sustainability information: personal cards, business cards and services, travel services, gift cards, prepaid cards, merchant services, Accertify, Business Blueprint, Resy, corporate card, business travel, diversity and inclusion, corporate sustainability and Environmental, Social, and Governance reports.

1Survey Methodology: This poll was conducted between January 31 – February 8, 2024 among a sample of 2,005 US Adults, 1,007 Australia Adults, 1,002 Canada, 1,002 UK Adults, 1,002 Japan Adults, 1,006 Mexico Adults and 1,005 India Adults who have at least a $50k+ income equivalent and typically travel at least once a year. The interviews were conducted online. Results from the full survey have a margin of error of plus or minus 2-4 percentage points. Some geographies may be weighted with fewer variables depending on local census data availability.

2Millennials and Gen Z are defined as respondents as being born between 1981 - 2012.

3GenX are defined as respondents as being born between 1965 - 1980.

4Baby Boomers are defined as respondents as being born between 1946 - 1964.

Seller of Travel

American Express Travel Related Services Company, Inc. is acting solely as a sales agent for travel suppliers and is not responsible for the actions or inactions of such suppliers. Certain suppliers pay us commission and other incentives for reaching sales targets or other goals and may provide incentives to our Travel Consultants. For more information visit www.americanexpress.com/travelterms.

California CST#1022318; Washington UBI#600-469-694

Source: American Express Company

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240312265470/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye